Fundz

Medtech Company Current Surgical Raises $3.2 Million Seed Round Led By True Ventures

PRIVATEFeb 21, 2023

Amount Raised

$3.2 Million

Round Type

Seed

WashingtonBiotechnologyHealth CareMedicalTherapeutics

Investors

National Science FoundationSci Founders1517 FundTrue Ventures

Description

Current Surgical Inc. today announced a $3.2 million seed funding round led by True Ventures, with participation from 1517 Fund and SciFounders. The Washington, DC-based medtech company is developing a software-enabled surgical platform to allow doctors to precisely and curatively treat a range of diseases. Since co-founders Alireza (Al) Mashal, PhD, and Chris Wagner, PhD, started Current Surgical in 2020, the company has raised $4 million in total, including a Small Business Innovation Research grant from the National Science Foundation.

Quick answer

Current Surgical raised $3.2 Million in a Seed round, dated February 21, 2023. Investors: National Science Foundation, Sci Founders, 1517 Fund and True Ventures. Current Surgical is based in Washington, United States.

How much did Current Surgical raise?
Current Surgical raised $3.2 Million in a Seed round on February 21, 2023.
Who invested in Current Surgical?
National Science Foundation, Sci Founders, 1517 Fund and True Ventures are named as investors in this round.
What does Current Surgical do?
Current Surgical is a preclinical-stage company enabling a new generation of hybrid therapies through the development of smart surgical tools to allow doctors to precisely treat currently untreatable solid tumors.
Where is Current Surgical based and how big is it?
Current Surgical is based in Washington, United States.
Who are the decision-makers at Current Surgical?
Fundz holds 1 contact at Current Surgical, including the Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Current Surgical that raised within 45 days of this round, from Fundz verified event records.

  • Transcend Therapeutics raised an undisclosed amount (Series A) on February 23, 2023.
  • Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.
  • HBM Alpha Therapeutics raised an undisclosed amount (Seed) on January 26, 2023.
  • OXOS Medical raised $23M (Series A) on April 5, 2023.
  • Wilson Wolf Manufacturing raised an undisclosed amount on April 3, 2023.
  • PureIMS raised an undisclosed amount on April 3, 2023.

Who to call at Current Surgical, and when

A new round usually means Current Surgical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Current Surgical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Current Surgical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Current Surgical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Current Surgical

Location

Washington, United States

About

Current Surgical is a preclinical-stage company enabling a new generation of hybrid therapies through the development of smart surgical tools to allow doctors to precisely treat currently untreatable solid tumors. For more on Current Surgical, please visit www.currentsurgical.com and follow along on LinkedIn and Twitter @CurrentSurgical.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Current Surgical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsChristopher W., Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Current Surgical's next move

See what Strategic adds

Current Surgical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.